DEUTSCHE BANK AG\
BankPosition in SRPT — Sarepta Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in SRPT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,043,619
+$1,767,268 QoQ
Shares Held
113,724
+795.5% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. SRPT ranks #112 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,043,619 | 113,724 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $276,351 | 12,700 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $258,023 | 11,990 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $184,721 | 9,586 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,292,733 | 134,078 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $106,169,227 | 1,663,573 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $202,246,603 | 1,663,349 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $182,736,050 | 1,463,176 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $248,625,166 | 1,573,577 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $189,073,093 | 1,460,475 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $142,230,583 | 1,474,962 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $129,840,922 | 1,071,118 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $126,739,512 | 1,106,702 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $137,846,675 | 1,000,121 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $121,816,602 | 940,088 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $82,588,300 | 747,135 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $51,579,449 | 688,093 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $59,428,303 | 760,731 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $65,287,058 | 725,009 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $43,268,152 | 467,865 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $34,875,638 | 448,619 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $37,989,056 | 509,715 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $87,925,441 | 515,722 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $71,940,319 | 512,286 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $116,671,719 | 727,652 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $84,779,220 | 866,686 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||